✦ LIBER ✦

Clinical study of FOLFOX4 regimen for patients of advanced hepatocellular carcinoma

✍ Scribed by Hua Zhu; Ping Sun

Book ID: 113059049
Publisher: Springer
Year: 2012
Tongue: English
Weight: 298 KB
Volume: 11
Category: Article
ISSN: 1610-1979
DOI: 10.1007/s10330-011-0934-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical analysis of HCPT plus FOLFOX4 r

Clinical analysis of HCPT plus FOLFOX4 regimen as salvage therapy for patients with advanced gastric cancer

✍ Xiaoqiang Fan; Xijian Zhou; Xiangyong Li; Xinyu Tang; Rengui Zhou; Dejian Pan 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 74 KB

The clinical research of elemene emulsio

The clinical research of elemene emulsion combined with FOLFOX4 regimen in the treatment of advanced gastric carcinoma

✍ Bi, Yanzhi; Zeng, Dongxiang; Ling, Yang 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 332 KB

Clinical observation of colon carcinoma

Clinical observation of colon carcinoma treated with Boerning capsules plus FOLFOX4 regimen

✍ Ping Liu; Jianhui Liu; Daoqi Zhu; Jin’an Ma; Chunhong Hu 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 283 KB

Clinical observation of Fufangchangtai d

Clinical observation of Fufangchangtai decoction combined with FOLFOX4 regimen for postoperative colorectal cancers

✍ Lingchang Li; Mingzhi Fang; Xiaoning Wang; Jiege Huo 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 196 KB

Phase II study of gemcitabine in patient

Phase II study of gemcitabine in patients with advanced hepatocellular carcinoma

✍ Tai-Shen Yang; Yung-Chang Lin; Jen-Shi Chen; Hung-Ming Wang; Chen-Hsu Wang 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 3 views

Phase 2 study of cetuximab in patients w

Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma

✍ Andrew X. Zhu; Keith Stuart; Lawrence S. Blaszkowsky; Alona Muzikansky; Donald P 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 1 views

## Abstract ## BACKGROUND. Epidermal growth factor receptor (EGFR) and ligand expression is frequently seen in hepatocellular carcinoma (HCC). A phase 2 study was performed with cetuximab, a chimeric monoclonal antibody that binds specifically to EGFR, in patients with advanced HCC. ## METHODS.